KYTX – kyverna therapeutics, inc. (US:NASDAQ)
Stock Stats
News
ROSEN, A TOP RANKED LAW FIRM, Encourages Kyverna Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – KYTX
Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025 - KYTX
Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 202- KYTX
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - KYTX
KYTX Class Action Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Kyverna Therapeutics, Inc. Class Action
Form S-8 Kyverna Therapeutics,
Form 8-K Kyverna Therapeutics, For: Nov 26
Form 10-Q Kyverna Therapeutics, For: Sep 30
Form 8-K Kyverna Therapeutics, For: Nov 08
Form SC 13G Kyverna Therapeutics, Filed by: Westlake BioPartners Fund I, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.